Skip to main content
Fresenius SE & Co. KGaA (FSNUF)
OTCMKTS · Delayed Price · Currency is USD
37.73
-3.28 (-8.00%)
At close: Apr 7, 2025

Fresenius SE & Co. KGaA Revenue

Fresenius SE & Co. KGaA had revenue of 5.65B EUR in the quarter ending March 31, 2025, with 5.63% growth. This brings the company's revenue in the last twelve months to 22.13B, down -1.26% year-over-year. In the year 2024, Fresenius SE & Co. KGaA had annual revenue of 21.83B with 3.64% growth.

Revenue (ttm)
22.13B EUR
Revenue Growth
-1.26%
P/S Ratio
1.14
Revenue / Employee
125.42K EUR
Employees
176,486
Market Cap
27.23B USD

Revenue Chart

* This company reports financials in EUR.

History

Fiscal Year End Revenue Change Growth
Dec 31, 202421.83B766.00M3.64%
Dec 31, 202321.07B-465.00M-2.16%
Dec 31, 202221.53B-15.99B-42.61%
Dec 31, 202137.52B1.24B3.43%
Dec 31, 202036.28B868.00M2.45%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Endo Inc. 1.73B
Veradigm 588.02M
Tian'an Technology Group 1.78M
Glass House Brands 200.90M
Elite Pharmaceuticals 70.00M
Northwest Biotherapeutics 1.38M
BioStem Technologies 301.83M
American Oncology Network 1.76B
Revenue Rankings

Fresenius SE & Co. KGaA News

More News